{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:56:37Z","timestamp":1777424197038,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry & Cell Biology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.biocel.2012.12.016","type":"journal-article","created":{"date-parts":[[2012,12,29]],"date-time":"2012-12-29T00:28:38Z","timestamp":1356740918000},"page":"657-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo"],"prefix":"10.1016","volume":"45","author":[{"given":"Jian","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Huan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Ze","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shen-Jiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biocel.2012.12.016_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1023\/A:1007185711745","article-title":"Rho plays an important role in angiotensin II-induced hypertrophic responses in cardiac myocytes","volume":"212","author":"Aikawa","year":"2000","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0010","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.RES.84.4.458","article-title":"Rho family small G proteins play critical roles in mechanical stress-induced hypertrophic responses in cardiac myocytes","volume":"84","author":"Aikawa","year":"1999","journal-title":"Circulation Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.RES.82.6.666","article-title":"Angiotensin II activates RhoA in cardiac myocytes: a critical role of RhoA in angiotensin II-induced premyofibril formation","volume":"82","author":"Aoki","year":"1998","journal-title":"Circulation Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0020","first-page":"H8","article-title":"Does load-induced ventricular hypertrophy progress to systolic heart failure","volume":"289","author":"Berenji","year":"2005","journal-title":"American Journal of Physiology: Heart and Circulatory Physiology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0025","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM199411103311907","article-title":"Transforming growth factor-b in tissue fibrosis","volume":"331","author":"Border","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2012.12.016_bib0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0008-6363(00)00092-4","article-title":"Renin\u2013angiotensin\u2013aldosterone system and myocardial fibrosis","volume":"47","author":"Brilla","year":"2000","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1126\/science.7716512","article-title":"Protein lipidation in cell signaling","volume":"268","author":"Casey","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.biocel.2012.12.016_bib0040","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0008-6363(98)00121-7","article-title":"Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts","volume":"40","author":"Gray","year":"1998","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev.cb.10.110194.000335","article-title":"Small GTP-binding proteins and the regulation of the actin cytoskeleton","volume":"10","author":"Hall","year":"1994","journal-title":"Annual Review of Cell Biology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1253\/circj.CJ-10-1101","article-title":"Alteration of enzyme expressions in mevalonate pathway: possible role for cardiovascular remodeling in spontaneously hypertensive rats","volume":"75","author":"Han","year":"2011","journal-title":"Circulation Journal"},{"key":"10.1016\/j.biocel.2012.12.016_bib0055","first-page":"183","article-title":"Pathophysiology of heart failure and the renin\u2013angiotensin-system","volume":"88","author":"Holtz","year":"1993","journal-title":"Basic Research in Cardiology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0060","doi-asserted-by":"crossref","first-page":"7725","DOI":"10.1074\/jbc.273.13.7725","article-title":"The low molecular weight GTPase Rho regulates myofibril formation and organization in neonatal rat ventricular myocytes. Involvement of Rho kinase","volume":"273","author":"Hoshijima","year":"1998","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0065","doi-asserted-by":"crossref","first-page":"2943","DOI":"10.1007\/s00421-011-2270-z","article-title":"Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats","volume":"112","author":"Ho","year":"2012","journal-title":"European Journal of Applied Physiology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0070","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1097\/01.ASN.0000076079.02452.92","article-title":"Cytoskeletal rearrangement and signal transduction in TGF-beta1-stimulated mesangial cell collagen accumulation","volume":"14","author":"Hubchak","year":"2003","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0075","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/01.CIR.104.3.346","article-title":"Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension","volume":"104","author":"Ichihara","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0080","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.0000221605.94532.71","article-title":"Long-term administration of rho-kinase inhibitor ameliorates renal damage inmalignant hypertensive rats","volume":"47","author":"Ishikawa","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.biocel.2012.12.016_bib0085","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF00408663","article-title":"Effect of angiotensin II on myocardial collagen gene expression","volume":"163\/164","author":"Ju","year":"1996","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1161\/01.CIR.0000030181.63741.56","article-title":"Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense","volume":"106","author":"Kagiyama","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0095","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1161\/01.HYP.25.6.1252","article-title":"Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats","volume":"25","author":"Kim","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.biocel.2012.12.016_bib0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/jpet.301.2.459","article-title":"Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats","volume":"301","author":"Kobayashi","year":"2002","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.biocel.2012.12.016_bib0105","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1172\/JCI44824","article-title":"Pivotal role of cardiomyocyte TGF-beta signaling in the murine pathologicalresponse to sustained pressure overload","volume":"121","author":"Koitabashi","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0110","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","article-title":"Potential therapeutic targets for cardiac fibrosis: TGF beta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation","volume":"106","author":"Leask","year":"2010","journal-title":"Circulation Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0115","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.biocel.2012.12.016_bib0120","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1046\/j.1432-1033.2002.03014.x","article-title":"Structure, mechanism and function of prenyltransferases","volume":"269","author":"Liang","year":"2002","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0125","first-page":"54","article-title":"Alterations in gene expression of series key enzymes in mevalonic acid pathway detected by RNA array in spontaneously hypertensive rats","volume":"24","author":"Li","year":"2008","journal-title":"Chinese Journal of Pathophysiology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bcp.2009.08.033","article-title":"Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats","volume":"79","author":"Li","year":"2010","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0135","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0140","doi-asserted-by":"crossref","first-page":"5590","DOI":"10.1073\/pnas.95.10.5590","article-title":"Signal transduction and activator of transcription (STAT) protein-dependent activation of angiotensinogen promoter: a cellular signal for hypertrophy in cardiac muscle","volume":"95","author":"Mascareno","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.biocel.2012.12.016_bib0145","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00018-005-5298-6","article-title":"Isoprenylated proteins","volume":"63","author":"McTaggart","year":"2006","journal-title":"Cellular and Molecular Life Sciences"},{"key":"10.1016\/j.biocel.2012.12.016_bib0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1007895222149","article-title":"Guanabenz combination therapy inhibits sympathetic nerve activity and regresses left ventricular hypertrophy","volume":"14","author":"Miyajima","year":"2000","journal-title":"Cardiovascular Drugs and Therapy"},{"key":"10.1016\/j.biocel.2012.12.016_bib0155","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1124\/jpet.111.182600","volume":"339","author":"Moey","year":"2011","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.biocel.2012.12.016_bib0160","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/01.RES.84.9.1073","article-title":"Angiotensin II-induced transactivation of epidermal growth factor receptor regulates fibronectin and transforming growth factor-beta synthesis via transcriptional and posttranscriptional mechanisms","volume":"84","author":"Moriguchi","year":"1999","journal-title":"Circulation Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0165","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1749-799X-3-51","article-title":"Effect of combined treatment with alendronate and calcitriol on femoral neck strength in osteopenic rats","volume":"3","author":"Nakamura","year":"2008","journal-title":"Journal of Orthopaedic Surgery and Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.HYP.0000040262.48405.A8","article-title":"Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling","volume":"40","author":"Ogihara","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.biocel.2012.12.016_bib0175","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/jmcc.2000.1303","article-title":"Myocardial ischemia activates the JAK\u2013STAT pathway through angiotensin II signaling in in vivo myocardium of rats","volume":"33","author":"Omura","year":"2001","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0180","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1677\/joe.0.1670525","article-title":"Possible interactions between angiotensin II and insulin: effects on glucose and lipid metabolism in vivo and in vitro","volume":"167","author":"Patiag","year":"2000","journal-title":"Journal of Endocrinology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0185","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/01.CIR.99.21.2750","article-title":"Dilated cardiomyopathy is associated with significant changes in collagen typeI\/III ratio","volume":"99","author":"Pauschinger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00218354","article-title":"Squalene synthetase","volume":"27","author":"Popjak","year":"1979","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0195","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI2552","article-title":"A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy","volume":"102","author":"Pracyk","year":"1998","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0200","first-page":"H1253","article-title":"Alterations of beta-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-beta(1)","volume":"283","author":"Rosenkranz","year":"2002","journal-title":"American Journal of Physiology: Heart and Circulatory Physiology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0205","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/j.1460-2075.1996.tb00413.x","article-title":"The heterotrimeric Gq protein-coupled angiotensin II receptor activates p21 ras via the tyrosine kinase\u2013Shc\u2013Grb2\u2013Sos pathway in cardiac myocytes","volume":"15","author":"Sadoshima","year":"1996","journal-title":"EMBO Journal"},{"key":"10.1016\/j.biocel.2012.12.016_bib0210","doi-asserted-by":"crossref","first-page":"31185","DOI":"10.1074\/jbc.271.49.31185","article-title":"Rho is required for Galphaq and alpha1-adrenergic receptor signaling in cardiomyocytes. Dissociation of Ras and Rho pathways","volume":"271","author":"Sah","year":"1996","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0215","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI6842","article-title":"Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure","volume":"103","author":"Sah","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.biocel.2012.12.016_bib0220","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S8756-3282(02)00738-X","article-title":"Effect of insulin-like growth factor-1 (IGF-1) plus alendronate on bone density during puberty in IGF-1-deficient MIDI mice","volume":"30","author":"Stabnov","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.biocel.2012.12.016_bib0225","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-binding proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.biocel.2012.12.016_bib0230","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.HYP.32.2.273","article-title":"Early induction of transforming growth factor-beta via angiotensin II type 1receptors contributes to cardiac fibrosis induced by long-term blockade of nitricoxide synthesis in rats","volume":"32","author":"Tomita","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.biocel.2012.12.016_bib0235","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ab.2008.04.021","article-title":"Quantitative determination of farnesyl and geranylgeranyl diphosphate levels in mammalian tissue","volume":"378","author":"Tong","year":"2008","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/j.biocel.2012.12.016_bib0240","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.biocel.2010.09.010","article-title":"Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy","volume":"42","author":"Ye","year":"2010","journal-title":"International Journal of Biochemistry and Cell Biology"},{"key":"10.1016\/j.biocel.2012.12.016_bib0245","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/j.febslet.2009.08.034","article-title":"Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA\/Rho kinase pathway","volume":"583","author":"Ye","year":"2009","journal-title":"FEBS Letters"},{"key":"10.1016\/j.biocel.2012.12.016_bib0250","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cardiores.2006.06.024","article-title":"Essential role of Rho\/ROCK-dependent processes and actin dynamics in mediating leptin-induced hypertrophy in rat neonatal ventricular myocytes","volume":"72","author":"Zeidan","year":"2006","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/cvr\/cvm020","article-title":"Leptin-induced cardiomyocyte hypertrophy involves selective caveolae and RhoA\/ROCK-dependent p38 MAPK translocation to nuclei","volume":"77","author":"Zeidan","year":"2008","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.biocel.2012.12.016_bib0260","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice","volume":"6","author":"Zhang","year":"2000","journal-title":"Nature Medicine"}],"container-title":["The International Journal of Biochemistry & Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272512004128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272512004128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T06:47:21Z","timestamp":1761202041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272512004128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1357272512004128"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2012.12.016","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2012.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}